CT-996
Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus
Carmot Australia First Pty Ltd · Phase 1 · Completed · Enrollment 94
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Part 1: CT-996 SAD Cohort 1 | n/r | n/r | n/r | n/r | n/r |
| Part 1: CT-996 SAD Cohort 2 | n/r | n/r | n/r | n/r | n/r |
| Part 1: CT-996 SAD Cohort 3, Then SAD Cohort 5 | n/r | n/r | n/r | n/r | n/r |
| Part 1: CT-996 SAD Cohort 4 | n/r | n/r | n/r | n/r | n/r |
| Part 1: CT-996 SAD Cohort 6 | n/r | n/r | n/r | n/r | n/r |
| Part 1: Placebo SAD Cohort | n/r | n/r | n/r | n/r | n/r |
| Part 2: CT-996 MAD Cohort 1 | n/r | n/r | n/r | n/r | n/r |
| Part 2: CT-996 MAD Cohort 2 | n/r | n/r | n/r | n/r | n/r |
| Part 2: CT-996 MAD Cohort 3 | n/r | n/r | n/r | n/r | n/r |
| Part 2: Placebo MAD Cohort | n/r | n/r | n/r | n/r | n/r |
| Part 3: CT-996 MD T2DM Cohort 1 | n/r | n/r | n/r | n/r | n/r |
| Part 3: CT-996 MD T2DM Cohort 2 | n/r | n/r | n/r | n/r | n/r |
| Part 3: Placebo MD T2DM Cohort | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.